Vanquix Auto-Injector for Acute Repetitive Seizures (ARS)

PurposeThe purpose of this study is to look at the safety and effectiveness of the Vanquix auto-injector compared to placebo (a medically inactive substance) when given to subjects with ARS by a caregiver.
Details Study Number
20060239
Accepts Adults?
Yes
Accepts Children?
Yes
Fully Enrolled?
No
Contacts Principal Investigator
A. James Fessler III, M.D.
Contact
Diane Smith, (585)275-0404

For More Information

Please call the phone number listed above and the clinical trial coordinator will contact you.